Dmitriy Kulakov

Mesenchymal Stromal Cells of Bone Marrow Reduce the Risk of Postoperative Recurrence of Crohn`s Disease

BACKGROUND: Crohn's disease (CD) in the form of terminal ileitis occurs in approximately 1/3 of CD patients and is often complicated by the formation of ileum stricture or ileocecal ...

Anait Babayan ;

Oleg Knyazev ;

Dmitriy Kulakov ;

Anna Kagramanova ;

Anatoliy Konoplyannikov ;

Asfold Parfenov ;

Mariya Zvyaglova ;

korneeva Irina ;

12/12/2019

Combined therapy with adalimumab and mesenchymal stromal cells contributes to reduction in the degree of inflammation in ulcerative colitis

BACKGROUND: One of the new promising methods of treatment of patients with ulcerative colitis (UC) is biological therapy using bone marrow mesenchymal stromal cells (MCS).

Marina Chernova ;

Oleg Knyazev ;

Sergey Khomeriki ;

Dmitriy Kulakov ;

Anna Kagramanova ;

Anatoliy Konoplyannikov ;

Albina Lishchinskaya ;

Asfold Parfenov ;

Mariya Zvyaglova ;

11/20/2018

P004 Steroid-Free Remission in Patients With Ulcerative Colitis Receiving Tofacitinib in Real Clinical Practice

BACKGROUND: Tofacitinib is a selective immunosuppressant, the first representative of the inhibitors of the janus kinase family, which has high selectivity against other kinas...

Irina Li ;

Anna Kagramanova ;

Tatyana Shkurko ;

Albina Lishchinskaya ;

Anait Babayan ;

Oleg Knyazev ;

Dmitriy Kulakov ;

12/15/2021